| IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia G Ishdorj, E Streu, P Lambert, HS Dhaliwal, SM Mahmud, SB Gibson, ... Blood advances 3 (14), 2188-2198, 2019 | 35 | 2019 |
| Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival G Ishdorj, S Beiggi, Z Nugent, E Streu, V Banerji, D Dhaliwal, SM Mahmud, ... Leukemia & lymphoma 60 (13), 3204-3213, 2019 | 27 | 2019 |
| Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia N Bourrier, I Landego, O Bucher, M Squires, E Streu, I Hibbert, ... BMC cancer 22 (1), 148, 2022 | 5 | 2022 |
| The efficacy and cost effectiveness of subcutaneous immunoglobulin (SCIG) replacement in patients with immune deficiency secondary to chronic lymphocytic leukemia E Streu, V Banerji, DHS Dhaliwal Blood 128 (22), 4778, 2016 | 5 | 2016 |
| Virchow’s Node and Carcinoma of Unknown Primary E Streu Number 6/November 2015 42 (6), 688-690, 2015 | 5 | 2015 |
| Subcutaneous immunoglobulin in oncology clinical practice E Streu Number 4/August 2016 20 (4), 437-439, 2016 | 4 | 2016 |
| Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report E Streu, MC Wiseman, JB Johnston SAGE Open Medical Case Reports 8, 2050313X19901071, 2020 | 2 | 2020 |
| Severe obesity in cancer care E Streu Number 3/May 2016 43 (3), 273-276, 2016 | 2 | 2016 |
| Hairy cell leukemia and bone pain E Streu Number 1/January 2016 43 (1), 18-21, 2016 | 2 | 2016 |
| The development and implementation of a subcutaneous immunoglobulin (SCIG) program at CancerCare Manitoba E Streu Canadian OnCOlOgy nursing JOurnal 26 (2), 137, 2016 | 2 | 2016 |
| Malakoplakia after allogeneic hematopoietic stem cell transplantation T Robinson Number 5/September 2015 42 (5), 558-561, 2015 | 2 | 2015 |
| Second malignancies in chronic lymphocytic leukemia RN Erin Streu Oncology Nursing Forum 41 (1), 95, 2014 | 2 | 2014 |
| The evolving context of driver mutations: ROS1 rearrangement in metastatic non-small cell lung cancer X DeCaire Number 5/September 2016 43 (5), 544-547, 2016 | 1 | 2016 |
| A population based-cohort review chronic lymphocytic leukemia (CLL) in a single Canadian center J Johnston, O Bucher, B Tordon, Z Nugent, I Landego, K Uminski, ... LEUKEMIA & LYMPHOMA 61, 258-259, 2020 | | 2020 |
| A Descriptive Analysis of Obinutuzumab Usage in a Single Canadian Centre N Bourrier, I Landego, M Squires, O Bucher, Z Aurangzeb, E Streu, ... Blood 132, 5838, 2018 | | 2018 |
| Revelance of Gammaglobulin Levels at Diagnosis and during Disease Course in Chronic Lymphocytic Leukemia E Streu, J Bi, M DeSousa, V Banerji, DHS Dhaliwal, S Beiggi, JB Johnston Blood 128 (22), 5561, 2016 | | 2016 |
| Élaboration et mise en place par ActionCancer Manitoba d’un programme d’administration d’immunoglobuline par voie sous-cutanée E Streu Canadian OnCOlOgy nursing JOurnal 26 (2), 145, 2016 | | 2016 |
| CONFÉRENCE SUR LA PRATIQUE CLINIQUE DE L’ACIO-CANO Élaboration et mise en place par ActionCancer Manitoba d’un programme d’administration d’immunoglobuline par voie sous-cutanée E Streu Canadian Oncology Nursing Journal/Revue canadienne de soins infirmiers en …, 2016 | | 2016 |
| Richter Syndrome: An Aggressive Transformation E Streu Number 2/March 2015 42 (2), 200-203, 2015 | | 2015 |
| CANO Chapters' corner. E Streu, K Fitzgerald, M Swidzinski Canadian Oncology Nursing Journal 21 (1), 2011 | | 2011 |
